Araris Biotech (Acquisition)

Funding Details
Date Award
May 18, 2025
Vertical
Biotechnology
Funding URL
View Funding Page
Valuation
$740,000,000

Company Info
Organizations Involved
Taiho Pharmaceutical
Company Description
Araris Biotech is known for developing innovative antibody-drug conjugates (ADCs) and is being acquired by Taiho Pharmaceutical to accelerate ADC drug discovery.
Market
Oncology
Location
Switzerland

Links
Back to Home Back to Biotechnology Deals View Funding Announcement